- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imatron crosses Atlantic with HeartScan
Ultrafast CT developer Imatron of South San Francisco, CA, saidthat it plans to open HeartScan imaging centers in Europe in cooperationwith major medical centers. Imatron launched the HeartScan program in the U.S. in 1994to provide coronary artery
Ultrafast CT developer Imatron of South San Francisco, CA, saidthat it plans to open HeartScan imaging centers in Europe in cooperationwith major medical centers.
Imatron launched the HeartScan program in the U.S. in 1994to provide coronary artery disease scanning using Imatron's UltrafastCT scanners. Imatron often markets the services of the clinicsdirectly to the public.
Imatron will adopt a similar strategy in Europe. The companyis in discussions with medical centers in Monte Carlo and Switzerlandas well as in Germany, where a syndicate is interested in openingthree HeartScan centers.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
